Literature DB >> 10221852

Inappropriate use of digoxin in the elderly: how widespread is the problem and how can it be solved?

G J Haas1, J B Young.   

Abstract

Cardiovascular disease is ubiquitous within the elderly population and requires treatment with multiple types of medications. As with any cardiovascular pharmaceutical regimen, the risk versus the benefit of each medication must be strongly considered. This is particularly true where, for various reasons, adverse effects are more often prevalent and pronounced. Over the years, it has been documented that digoxin is a frequently prescribed medication in elderly populations. Although this drug can be beneficial when used in the appropriate setting, recent data would suggest that inappropriate administration of digoxin is common and not without potentially serious consequences. Currently, the use of digoxin can be advocated to control heart failure in atrial fibrillation and when added to ACE inhibitors and diuretics in those patients with symptomatic heart failure related to systolic left ventricular dysfunction. It is likely that the excessive use of digoxin in elderly populations as discussed in this review is perhaps based on the prevalence of diastolic heart failure in the elderly as well as other co-morbid conditions that may mimic heart failure signs and symptoms. Since the elderly appear to be at high risk for digoxin toxicity, the inappropriate use of this medication to treat these conditions could result in significant and unnecessary morbidity. It is proposed that echocardiography should be performed in most elderly patients when congestive heart failure is suspected. This simple diagnostic tool, along with a careful history and medical examination, would hopefully prevent the misinterpretation of confusing clinical findings and would help to identify the patients with normal systolic function or valvular disease such as critical aortic stenosis, where digoxin treatment would not be warranted. If it is necessary to administer digoxin, then the likelihood of significant toxicity can be greatly reduced by using an algorithm to calculate the appropriate dosage, which takes into consideration the patient's gender, bodyweight and creatinine clearance. Although it is probable that the indications for digoxin use to treat congestive heart failure will continue to evolve, at the present time most would recommend using this agent in symptomatic heart failure related to a reduction in left ventricular systolic function or when associated with atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221852     DOI: 10.2165/00002018-199920030-00003

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  32 in total

1.  Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease.

Authors:  W S Aronow; C Ahn; I Kronzon
Journal:  Am J Cardiol       Date:  1990-11-15       Impact factor: 2.778

Review 2.  Age and the cardiovascular system.

Authors:  J Y Wei
Journal:  N Engl J Med       Date:  1992-12-10       Impact factor: 91.245

3.  Diastolic dysfunction in elderly patients with congestive heart failure.

Authors:  W F Wong; S Gold; O Fukuyama; P L Blanchette
Journal:  Am J Cardiol       Date:  1989-06-15       Impact factor: 2.778

Review 4.  Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions.

Authors:  L Nolan; K O'Malley
Journal:  J Am Geriatr Soc       Date:  1988-02       Impact factor: 5.562

5.  Adverse influence of baroreceptor dysfunction on upright exercise in congestive heart failure.

Authors:  G W Stone; S H Kubo; R J Cody
Journal:  Am J Med       Date:  1986-05       Impact factor: 4.965

6.  Large-scale digitoxin intoxication.

Authors:  A H Lely; C H van Enter
Journal:  Br Med J       Date:  1970-09-26

7.  Alterations of coronary blood flow and reserve with aging in Fischer 344 rats.

Authors:  R Hachamovitch; P Wicker; J M Capasso; P Anversa
Journal:  Am J Physiol       Date:  1989-01

8.  Digitalis: its place in modern therapy.

Authors:  A J Taggart; D G McDevitt
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

Review 9.  Drug therapy in the elderly.

Authors:  J G Ouslander
Journal:  Ann Intern Med       Date:  1981-12       Impact factor: 25.391

10.  Relationship between the administration of selected medications and falls in hospitalized elderly patients.

Authors:  B J Gales; S M Menard
Journal:  Ann Pharmacother       Date:  1995-04       Impact factor: 3.154

View more
  3 in total

1.  Torasemide: a pharmacoeconomic review of its use in chronic heart failure.

Authors:  M Young; G L Plosker
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Utilization of potentially inappropriate medications in elderly patients in a tertiary care teaching hospital in India.

Authors:  Binit N Jhaveri; Tejas K Patel; Manish J Barvaliya; Chandrabhanu Tripathi
Journal:  Perspect Clin Res       Date:  2014-10

3.  Polypharmacy in elderly patients at discharge from the acute care hospital.

Authors:  Andrea Corsonello; Claudio Pedone; Francesco Corica; Raffaele Antonelli Incalzi
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.